(Reuters) – The U.S. health regulator said on Thursday the current emergency use authorization (EUA) for Pfizer’s COVID-19 antiviral pill for high-risk adolescents will continue to remain in effect even if it receives full approval for use in some adults.
Latest posts by Crypto Editor (see all)
- FP Markets Webinar for January 31: Explore TradingView with FP Markets Market Analyst Aaron Hill - January 18, 2024
- Crude Oil Price Forecast – Crude Oil Continues to Bounce Around - January 18, 2024
- AUD/USD Forecast – Australian Dollar Continues to Test Support - January 18, 2024